Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D.
Liver Int
; 44(1): 139-147, 2024 01.
Article
in En
| MEDLINE
| ID: mdl-37787009
Full text:
1
Collection:
01-internacional
Health context:
2_ODS3
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Hepatitis D
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Liver Int
Year:
2024
Document type:
Article